Clinical Trials Browser

Interventional × Malignant Solid Tumors × Topotecan × Clear all

NCT00516438 2010-12-08

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumors